New vaccine formulas from Pfizer / BioNTech, Moderna, and Novavax were approved in September 2023, for everyone over 6 months old.
These webpages will be updated when more details are known - check back often.
It makes sense to optimize the timing of when to get vaccinated against COVID to give the strongest and most long-lasting protection, but there isn't clear guidance. Some of the factors to consider are:
Current advice from CDC and other experts to people who have recently recovered from COVID:
Getting the vaccine - make an appointment or find a walk-in location:
Starting May 2023, health insurance companies have been rolling COVID vaccines into their medication coverage plans. There should still be no charge to get vaccinated, but there may be limits on where and how we can get them. Per the Your Local Epidemiologist blog:
"Private insurance companies are mandated to cover this vaccine with no copay. What has changed since last year? Insurers are no longer required to pay for “out-of-network”. You may need to get your vaccine at your doctor’s office if your pharmacy is not in-network with your insurance plan.
Uninsured or underinsured adults: CVS/Walgreens are required by federal law to cover your vaccine at no cost to you, thanks to the new Bridge Program. This is just for COVID, not for RSV, unfortunately.
Uninsured or underinsured kids: Vaccines for Children cover all kids' vaccines, not just COVID, for those that cannot pay."
Vaccinating Kids and Teens:
In Santa Clara County, children 5 and older can get vaccines and boosters at any of the locations where adults are vaccinated. Children younger than 5 years old should be vaccinated at their pediatrician's office. For Santa Clara County residents, if your child does not have a regular doctor, call (866) 967-4677 for assistance enrolling in government programs or health coverage.
Vaccinating any child or teen requires permission of their parent or legal guardian (with some exception for teens 12+). The permission form is online, or can be filled out on location.
Information on the side effects of these vaccines, and precautions to take:
After getting vaccinated, sign up with the CDC's reporting system to record your reactions, and help to push our knowledge of how to treat this novel disease forward. Sign up after the first dose, for 2-part vaccines or after the 1-shot version.
Getting vaccinated now does not mean we can immediately go back to our pre-pandemic life. The hope is vaccines will save lives and keep fewer people from getting seriously ill, but they probably will not be able to stop the pandemic in its tracks quite yet. People who have been fully vaccinated (at least 14 days after their last vaccine dose) have fewer restrictions on wearing face masks and distancing, in some situations. (See the page in this guide for Slowing the Spread for details on where vaccinated people still need to take precautions.)
We are likely to need to keep taking some precautions until young children can be safely vaccinated and until worldwide infection rates are significantly lower.
Vaccines previously approved for use in the U.S. are by:
New vaccine formulas from Pfizer / BioNTech, Moderna, and Novavax have been approved for the fall 2023 - spring 2024 COVID season. These are monovalent, based on the most prevalent SARS-CoV-2 variations of concern in late summer 2023 (that is, in the same way that annual flu vaccines are created).
First-time COVID vaccination requires two doses approximately a month apart (28 days for the Pfizer vaccine, 21 days for Moderna. Boosters are one single dose.
As of October 2023, the CDC no longer issues COVID-19 vaccination cards.
As of this time, CA still maintains those records as part of its CAIR (California Immunization Registry). Individuals are encouraged to sign up with its Digital Vaccine Registry portal, and to update their records whenever they get a booster.
For people in Santa Clara County, here's advice from our county Public Health Department on how to update your information with CAIR:
Most of us have a really basic idea of how vaccines work: by they sensitive us to a specific disease, so when we're exposed to infection, we are already equipped to fight it off. That's not wrong, but immunity is rather more complex. There are several different types of vaccines; depending on type and depending on the disease, each with their own limitations on how completely they can protect us and for how long.
For a better understanding what vaccines can do for us, see:
How well our bodies resist infection - our immunity, in other words - depends on the strength of the antibodies created in our bodies and on how healthy we are overall. Active immunity (when our bodies create antibodies for ourselves) is stronger than passive immunity (when we are given antibodies from someone else) and also lasts longer.
Vaccine safety is a big concern to many in the U.S. There has been a lot of mis- and dis-information in the last decade on the topic of vaccines, especially vaccines for children. These sources will bust many of those myths:
The Centers for Disease Control and Prevention explains how they will make sure that the COVID-19 vaccines offered to the people of the U.S. are safe:
With familiar and well-known diseases like whooping cough (pertussis) or polio, we can measure the effectiveness of a vaccine, using past case history and statistics to figure out how many people were not infected because they got the vaccine, compared to unprotected people.
Effectiveness is impossible to calculate accurately for a new disease like the novel coronavirus. With COVID-19 the best we can do for now is measure efficacy (compare the number of cases in one group that got the vaccine, versus another control group that did not). And as one immunology textbook points out, when we look at vaccines, we are concerned with efficacy in three different areas:
1. Efficacy to prevent infection (also called sterilizing immunity)
2. Efficacy to prevent disease [getting sick and also transmitting the disease to others]
3. Efficacy to prevent severe disease
The currently-available vaccines for COVID-19 are good at 2. and 3. but they don't offer sterilizing immunity.
Clinical trials testing efficacy of vaccines need to be as diverse as the population they intend to help. When there's only a small number of people participating in a clinical trial, though, it's hard to have confidence that it will work on more than a narrow slice of the population. The current clinical trials for COVID-19 vaccines being considered in the U.S. are paying attention to that problem; and the National Institutes of Health's All of US program aims to recruit larger and much more diverse groups of people to participate in all kinds of clinical trials, to avoid further bias in healthcare.
The text on this page is copyright Lise M. Dyckman and PlaneTree Health Library, licensed under Creative Commons CC BY-NC-SA 4.0. Linked contents are the responsibility of their creators or copyright holders.